Key statistics
As of last trade Edwards Lifesciences Corp (EWL:STU) traded at 63.79, 7.10% above its 52-week low of 59.56, set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 63.95 |
|---|---|
| High | 64.94 |
| Low | 63.79 |
| Bid | 63.79 |
| Offer | 63.93 |
| Previous close | 64.32 |
| Average volume | 85.71 |
|---|---|
| Shares outstanding | 580.30m |
| Free float | 574.93m |
| P/E (TTM) | 42.00 |
| Market cap | 44.03bn USD |
| EPS (TTM) | 1.81 USD |
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Press releases
- Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
- Edwards Comments on JenaValve Acquisition
- FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
- Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
More ▼
